UNSPSC 51282307: Lexithromycin

This classification denotes a macrolide antibiotic with the molecular formula C38H70N2O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7QKO29734U, chemically known as erythromycin, 9-(o-methyloxime) but generally known as lexithromycin, which bears US NIH Compound Identifier 9570610. European Medicines Agency schedules Lexithromycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08499MIG.

UNSPSC 51282307 Lexithromycin is a Commodity code that captures individual pharmaceutical products and related medical supplies procured by state and local health agencies, emergency services, and correctional departments. Recent state and local opportunities under this code show purchasing across naloxone and drug deactivation systems for community health initiatives, generic multi-source pharmaceuticals and over-the-counter products distributed through state cooperative purchasing vehicles, and emergency medical supplies for first-responder agencies. The issuing bodies span state health commissions and departments of administration managing cooperative purchasing networks, county health departments, and municipal fire and rescue divisions; the work involves both one-time and recurring procurement of specific pharmaceutical products and medical consumables with firm pricing, compliance with Good Manufacturing Practices and Drug Supply Chain Security Act requirements, and delivery to designated facilities on established schedules.

Recent activity concentrates in Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2023. The City of Tampa's Purchasing Department posted IFB 26P00145 in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000 and a sheltered Small Local Business Enterprise set-aside with a 5 percent bid discount. The Minnesota Department of Administration issued RFP S1070000015802 through the MMCAP cooperative purchasing vehicle in January 2026 for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, with proposals due March 26, 2026 and awards effective July 1, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, with responses informing future formal procurement strategy.